Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33672 Results Found
CMS issues guidance on required Medicaid-CHIP COVID-19 coverage
The Centers for Medicare & Medicaid Services issued guidance on the American Rescue Plan Act requirement for state Medicaid and Children’s Health Insurance programs to cover certain COVID-19-related treatments without cost-sharing effective March 11, 2021.
HHS announces competition centered on improving postpartum care
The Department of Health and Human Services announced the HHS Racial Equity in Postpartum Care Challenge, a competition dedicated to upgrading postpartum care for Black and Native women enrolled in the Medicaid or CHIP programs.
CMS highlights state innovations to expand Medicaid home, community-based services
The Centers for Medicare & Medicaid Services launched for state Medicaid agencies and stakeholders on Medicaid.gov a webpage dedicated to advancing transparency and innovation for home and community-based services.
HHS extends shelf life for monoclonal antibody
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration extended the shelf life for the monoclonal antibody therapy etesevimab, which currently must be administered with bamlanivimab.
CDC endorses ACIP recommendations for COVID-19 boosters
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., recommended a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series for certain individuals at risk for severe COVID-19, as proposed by her agency’s Advisory Committee on Immunization Practices.
Social Determinants Accelerator Act introduced in Senate
Sens. Todd Young, R-Ind., and Debbie Stabenow, D-Mich., introduced the Social Determinants Accelerator Act, AHA-supported legislation that would provide planning grants and technical assistance to help states and communities address the social determinants of health for high-need patients.
Pfizer unveils new data on COVID-19 boosters, pediatric vaccines; confirms high efficacy for each
New data from Pfizer is indicating high efficacy for its COVID-19 vaccine as a booster, as well as its effectiveness among the 5-11 age group.
Rural Americans Lend Their Voices to Encourage Others to Get Vaccinated
As deaths due to COVID-19 increase disproportionately in rural communities, farmers, ranchers and other rural residents are opening up about the hardships they’ve faced.